Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia

Blood

Volumn 120, Issue 4, 2012, Pages 843-846

  Slager, Susan L ^a   Skibola, Christine F ^b   Di Bernardo, Maria Chiara ^c   Conde, Lucia ^b   Broderick, Peter ^c   McDonnell, Shannon K ^a   Goldin, Lynn R ^d   Croft, Naomi ^c   Holroyd, Amy ^c   Harris, Shelley ^c   Riby, Jacques ^b   Serie, Daniel J ^a   Kay, Neil E ^a   Call, Timothy G ^a   Bracci, Paige M ^e   Halperin, Eran ^f   Lanasa, Mark C ^g   Cunningham, Julie M ^a   Leis, Jose F ^a   Morrison, Vicki A ^h,i   Spector, Logan G ⁱ   Vachon, Celine M ^a   Shanafelt, Tait D ^a   Strom, Sara S ^j   Camp, Nicola J ^k   Weinberg, J Brice ^g,l   Matutes, Estella ^c   Caporaso, Neil E ^d   Wade, Rachel ^m   Dyer, Martin J S ⁿ   Dearden, Claire ^c   Cerhan, James R ^a   Catovsky, Daniel ^c   Houlston, Richard S ^c   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f TEL AVIV UNIVERSITY   (Israel)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h VETERANS AFFAIRS MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^l DURHAM VA MEDICAL CENTER   (United States)

^m UNIVERSITY OF OXFORD   (United Kingdom)

ⁿ UNIVERSITY OF LEICESTER   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BAK1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CHROMOSOME 6P; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84864471868     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-413591     Document Type: Article

References (20)

1. Stevenson FK, Caligaris-Cappio F. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood. 2004;103(12):4389-4395. (Pubitemid 38745961)
2. Goldin LR, Pfeiffer RM, Li X, Hemminki K. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood. 2004;104(6):1850-1854. (Pubitemid 39202296)
3. Slager SL, Rabe KG, Achenbach SJ, et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood. 2011;117(6):1911-1916.
4. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10):1204-1210.
5. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010;42(2):132-136.
6. Crowther-Swanepoel D, Di Bernardo MC, Jamroziak K, et al. Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk. Br J Haematol. 2011;154(2):229-233.
7. Swerdlow SH, Campo E, Harris N. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008.
8. Conde L, Halperin E, Akers NK, et al. Genomewide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010;42(8):661-664.
9. Penegar S, Wood W, Lubbe S, et al. National study of colorectal cancer genetics. Br J Cancer. 2007;97(9):1305-1309. (Pubitemid 350035800)
10. Eisen T, Matakidou A, Houlston R. Identification of low penetrance alleles for lung cancer: the GEnetic Lung CAncer Predisposition Study (GELCAPS). BMC Cancer. 2008;8:244.
11. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575. (Pubitemid 47330214)
12. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558. (Pubitemid 34746062)
13. Pharoah PD, Antoniou AC, Easton DF, Ponder BA. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med. 2008;358(26):2796-2803. (Pubitemid 351930854)
14. Chittenden T, Harrington EA, O'Connor R, et al. Induction of apoptosis by the Bcl-2 homologue Bak. Nature. 1995;374(6524):733-736.
15. Leu JI, George DL. Hepatic IGFBP1 is a prosurvival factor that binds to BAK, protects the liver from apoptosis, and antagonizes the proapoptotic actions of p53 at mitochondria. Genes Dev. 2007;21(23):3095-3109. (Pubitemid 350223527)
16. Takeuchi O, Fisher J, Suh H, Harada H, Malynn BA, Korsmeyer SJ. Essential role of BAX, BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci U S A. 2005;102(32):11272-11277. (Pubitemid 41153810)
17. Nica AC, Parts L, Glass D, et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 2011;7(2):e1002003.
18. Dai H, Meng XW, Lee SH, Schneider PA, Kaufmann SH. Context-dependent Bcl-2/Bak interactions regulate lymphoid cell apoptosis. J Biol Chem. 2009;284(27):18311-18322.
19. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94(6):1848-1854. (Pubitemid 29430400)
20. Weiss NS. Geographical variation in the incidence of the leukemias and lymphomas. Natl Cancer Inst Monogr. 1979;(53):139-142. (Pubitemid 10103237)